Sagimet Biosciences Inc.

SGMT·NASDAQ·$7.22Share Price as of 11/2·$235MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/11/26 10-QQ1 ended 03/31/2605/12/26 10-KFY 202503/11/26 10-QQ3 ended 09/30/2511/13/25 10-QQ2 ended 06/30/2508/13/25

Disclosures

8-KCurrent report10/22/26 8-KCurrent report10/01/26 8-KCurrent report09/30/26 8-KCurrent report08/13/26 8-KCurrent report08/11/26

Prospectuses and Registrations

424B5Prospectus supplement10/01/26 424B3Prospectus09/30/26 424B5Prospectus supplement04/28/26 S-8Registration of securities for employees03/11/26 S-8Registration of securities for employees03/11/26

Proxies

DEF 14ADefinitive proxy04/21/26 DEF 14ADefinitive proxy04/30/25 DEF 14ADefinitive proxy04/18/24 DEFA14AAdditional proxy materials04/18/24

Ownership

SC 13GBeneficial ownership10/07/26 Form 4Insider transaction08/17/26 144Proposed sale of securities08/14/26 SC 13GBeneficial ownership08/14/26 Form 4Insider transaction08/12/26

Other

ARSAnnual report to shareholders04/21/26 UPLOADLetter from the SEC05/07/25 CORRESPCorrespondence with the SEC05/05/25 ARSAnnual report to shareholders04/30/25 UPLOADLetter from the SEC04/22/25